A phase I clinical trial of an oral formulation of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA)
2008 ◽
Vol 81
(3)
◽
pp. 170-176
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3027-3027
◽
2012 ◽
Vol 18
(1)
◽
pp. 87-95
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 3027-3027
2007 ◽
Vol 121
(3)
◽
pp. 656-665
◽
2004 ◽
Vol 2
(4)
◽
pp. 243-248
◽
2015 ◽
Vol 7
(2)
◽
pp. 141-148
◽
2013 ◽